ARTICLE | Clinical News
Lytix Biopharma AS preclinical data
September 24, 2007 7:00 AM UTC
In mice, LTX-9 had activity against both Gram-positive and -negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The company hopes to submit an IND for the anti-microbial i...